{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T20:47:49Z","timestamp":1789764469485,"version":"4.0.1"},"reference-count":31,"publisher":"S. Karger AG","issue":"9","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/karger.com\/pages\/terms-and-conditions"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nephron"],"published-print":{"date-parts":[[2023]]},"abstract":"<jats:p>Introduction: Acute kidney injury (AKI) is a group of highly heterogeneous, complicated clinical syndromes. Although kidney biopsy plays an irreplaceable role in evaluating complex AKI, a few studies have focused on the clinicopathology of AKI biopsies. This study analyzed the pathological disease spectrum, causes, and renal outcomes of biopsied AKI patients. Methods: We retrospectively included 2,027 AKI patients who underwent kidney biopsies at a national clinical research center of kidney diseases from 2013 through 2018. To compare the biopsied AKI cases without and with coexisting glomerulopathy, patients were classified into acute tubular\/tubulointerstitial nephropathy-associated AKI (ATIN-AKI) and glomerular disease-associated AKI (GD-AKI) groups. Results: Of 2,027 biopsied AKI patients, 65.1% were male, with a median age of 43 years. A total of 1,590 (78.4%) patients had coexisting GD, while only 437 (21.6%) patients had ATIN alone. The AKI patients with GD mainly (53.5%) manifested as stage 1 AKI, while most ATIN-AKI patients (74.8%) had stage 3 AKI. In the ATIN-AKI group, 256 (58.6%) patients had acute interstitial nephritis (AIN), and 77 (17.6%) had acute tubular injury (ATI). ATIN-AKI was mainly caused by drugs in 85.5% of AIN and 63.6% of ATI cases, respectively. In AKI patients with coexisting GD, the leading pathological diagnoses in over 80% of patients were IgA nephropathy (IgAN, 22.5%), minimal change disease (MCD, 17.5%), focal segmental glomerulosclerosis (FSGS, 15.3%), lupus nephritis (LN, 11.9%), membranous nephropathy (MN, 10.2%), and ANCA-associated vasculitis (AAV, 4.7%). A total of 775 patients were followed up within 3 months after renal biopsy; ATIN-AKI patients achieved statistically higher complete renal recovery than the GD-AKI patients (83.5% vs. 70.5%, p &amp;lt; 0.001). Conclusions: Most biopsied AKI patients have coexisting GD, while ATIN alone is seen less frequently. ATIN-AKI is mainly caused by drugs. In GD-AKI patients, IgAN, MCD, FSGS, LN, MN, and AAV are the leading diagnoses. Compared to AKI patients without GD, patients with GD suffer from worse renal function recovery. <\/jats:p>","DOI":"10.1159\/000530615","type":"journal-article","created":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T21:00:34Z","timestamp":1682370034000},"page":"541-549","source":"Crossref","is-referenced-by-count":11,"title":["The Spectrum of Biopsy-Proven Kidney Diseases, Causes, and Renal Outcomes in Acute Kidney Injury Patients"],"prefix":"10.1159","volume":"147","author":[{"given":"Zulihumaer","family":"Abuduwupuer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qunjuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaoshan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xumeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3816-5164","authenticated-orcid":false,"given":"Caihong","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"127","published-online":{"date-parts":[[2023,4,24]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.184"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2012.01.016"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199605303342207"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2017.09.001"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5002729"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1159\/000349964"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)60126-X"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00710113"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1053\/ajkd.2002.32766"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1466-z"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)17831-3"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2012.02.330"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfy048"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2008.04.010"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1053\/j.ackd.2016.11.016"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2016.05.018"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.328"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0272-6386(00)70196-x"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04441007"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu326"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfg464"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2010.71"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2014.04.027"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1159\/000354088"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-019-00873-8"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-021-06503-y"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-197909000-00003"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1159\/000166768"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1159\/000484717"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12882-019-1514-8"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2007080837"}],"container-title":["Nephron"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/karger.com\/nef\/article-pdf\/147\/9\/541\/3996293\/000530615.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/karger.com\/nef\/article-pdf\/147\/9\/541\/3996293\/000530615.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T15:25:56Z","timestamp":1745421956000},"score":1,"resource":{"primary":{"URL":"https:\/\/karger.com\/article\/doi\/10.1159\/000530615"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":31,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2023,9,5]]},"published-print":{"date-parts":[[2023,9,18]]}},"URL":"https:\/\/doi.org\/10.1159\/000530615","archive":["Portico"],"relation":{},"ISSN":["1660-8151","2235-3186"],"issn-type":[{"value":"1660-8151","type":"print"},{"value":"2235-3186","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]}}}